Harvey Friedman
Infectious Disease · Philadelphia, PANPI 1447282728
Payments from drug & device makers
$2,308,338in general payments, 2019–2025
Across 599 payments — averaging $3853.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biontech SE$1.7M
- Shionogi Inc$590K
- Gilead$4K
What the payments were for
- Consulting fees$3,28077%
- Travel & lodging$51312%
- Food & beverage$44010%
General payments by program year
19
21
22
23
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biontech SE | 593 | $1,714,877 |
| Shionogi Inc | 2 | $589,549 |
| Gilead | 4 | $3,912 |
How this compares
$2,308,338 in reported general payments places this provider in the 95th percentile of 457 infectious disease providers in Pennsylvania.
Other infectious disease in Philadelphia
- Pablo TebasPhiladelphia$2.6M
- Kathryn WhitakerPhiladelphia$2.5M
- Ian FrankPhiladelphia$2.2M
- David HornPhiladelphia$2.1M
- Karam MounzerPhiladelphia$1.6M
- Kathleen DegnanPhiladelphia$1.4M
- Judith WolfPhiladelphia$1.2M
- William ShortPhiladelphia$1.1M
- Katherine BeldenPhiladelphia$806K
- Stephen GluckmanPhiladelphia$592K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.